A new dimension in procalcitonin testing has arrived.
Bring the most accurate and precise test closer to your ED with the new Dimension® EXL™ LOCI® BRAHMS Procalcitonin (PCT) assay from Siemens Healthineers.
Detecting and treating bacterial sepsis is a matter of life and death.
Every year more than 1.7 million people in the U.S. are diagnosed with sepsis and more than 270,000 people die from an advanced form of sepsis.1 Now you can improve sepsis diagnosis and treatment by integrating PCT testing into your Dimension® EXL™.
Bring PCT testing closer to your patients.
An early and accurate diagnosis could save precious time, expense, and most importantly, lives.
Precision when it matters most.
PCT is a more sensitive and precise biomarker for early detection of sepsis when compared to lactic acid, C-reactive protein (CRP) and Interleukin-6 (IL-6).2
Trusted technology, reliable results
Support risk stratification, prognosis, and antibiotic decision making for septic patients.
Contact sales about evaluating PCT on Dimension® EXL™!
Fast, accurate sepsis diagnosis with BRAHMS Procalcitonin (PCT) and Siemens Healthineers
Join Dr. Melanie Pollan of Siemens Healthineers for a comprehensive review of PCT and how it can be leveraged to manage patients with suspected bacterial infections.
Sepsis: Anyone at Any Time
More than 1.5 million people in the U.S. are diagnosed with sepsis each year. Download and share the infographic to help raise awareness.
PCT Literature Compendium
The ten articles comprising this compendium address these usages in different clinical care settings for pathologies of varying severity, and also provide evidence of the financial benefit of using PCT.
- Centers for Disease Control and Prevention, https://www.cdc.gov/sepsis/what-is-sepsis.html
- Journal of Intensive Care, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543591/